# Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

> **NCT00573222** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 330 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Symbicort

## Key facts

- **NCT ID:** NCT00573222
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2010-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573222, "Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00573222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*